Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
This recent regulatory update is a game-changer and a massive catalyst for the marijuana industry.


Keep up with what matters in ETFs
Get timely ETF insights, market trends, and top ideas straight to your inbox.
Your newsletter subscriptions with us are subject to ETF Central's Privacy Policy and Terms and Conditions.
The marijuana industry is finally experiencing a reprieve after years of underperformance following the 2018 "Weed Stock Mania." On October 6th, 2022, President Biden announced major reforms, which included:
Marijuana stocks and ETFs soared on the news. For example, the AdvisorShares Pure U.S. Cannabis ETF (MSOS) jumped nearly 40% intra-day as its underlying holdings surged. Other marijuana ETFs also saw strong inflows, signaling high amounts of investor interest.
Stay in the loop — get the latest ETF insights: trends, analysis, and expert picks.
Jason Wilson, Cannabis Banking Expert at ETFMG was of the opinion that the recent announcement was merely the beginning of a long-awaited and extensive cannabis reform process. Wilson told me:
"Although President Biden did not go as far as Germany recently has by announcing that they will table draft legalization legislation by the end of the year, the President’s acknowledgment that it is time to right the wrongs of the federal government’s failed approach to marijuana, combined with his instructions to the Secretary of Health and Human Sciences and the Attorney General to expeditiously review marijuana’s classification under federal laws, provide a strong and important political statement suggesting that long-awaited cannabis reform may arrive sooner than expected."
This is a highly bullish sentiment evidently shared and anticipated by the market for a long time ever since Biden's 2020 campaign promises. The surge in cannabis stocks was likely a result of the "surprise" from the sudden announcement of these reforms previously discounted as a more remote possibility.
What Wilson found particularly important was Biden's instructions to the Secretary of Health and Human Services and the Attorney General to expeditiously review marijuana’s status under federal law. Wilson noted that this action effectively commenced the process to reschedule or de-schedule cannabis altogether under the Controlled Substances Act, where it is currently classified as Schedule I, the same classification as the most dangerous substances like heroin and LSD.
That being said, Wilson does not anticipate Biden's actions alone having a short-term material impact on the cannabis industry. "The path to rescheduling or de-scheduling cannabis by way of executive action will be a long and bureaucratic process that will take some time to work through, but Biden's actions did add momentum," he says.
Investors interested in the marijuana industry can use a variety of ETFs to gain exposure. It's worth carefully examining each fund's construction, methodology, and strategy. Some things to note when conducting your analysis include:
Depending on your preferences for the above, the following ETFs might be suitable for expressing a long position in the marijuana industry:
Please note this article is for information purposes only and does not constitute investment advice.
Latest ETF News
See all ETF newsMoneyShow Chart of the Day 4/1/2026: Deal Volume Jumps in Q1 (But Will it PERSIST?)


MoneyShow Chart of the Day 3/9/2026: Tallying Up the Costs in Oil Markets


Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
What’sTheFund
What's the Fund | State Street SPDR IG Public & Private Credit ETF (Ticker: PRIV)
Matthew Bartolini, Global Head of Research Strategists, at State Street Investment Management, joins Ethan Hertzfeld on the New York Stock Exchange Floor to discuss PRIV, the State Street SPDR IG Public & Private Credit ETF.

ETF Trends
ETF Industry KPIs April 27, 2026
The ETF Industry saw 23 New Launches, 1 Ticker Change and 4 closures last week.

Asset TV
The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs
Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.

ETF Trends
ETF Industry KPIs April 20, 2026
The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.

Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
